Targeted Therapy for BRAF V600E Positive Pancreatic Adenocarcinoma: Two Case Reports.

These cases emphasize the importance of early next generation sequencing and the consideration of BRAF targeted treatment in this patient population, especially if a response to initial chemotherapy is not sustained.